Project Grant K23HD110710

Award Date 9/1/24
Completion Date 8/31/28
Dollars Obligated $163K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under CFDA Program 93.865 Child Health and Human Development Extramural Research, aims to identify the central and peripheral mechanisms underlying endometriosis pain and the changes in pain after lesion removal surgery. The $233,250 award, granted on April 1, 2025, will fund a study focused on examining the relationships between endometriosis pain, conditioned pain...
This federal Project Grant award, valued at $643,049.00 and issued by the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 Child Health and Human Development Extramural Research, will fund the development of a physiomimetic model of the endometrioma lesion microenvironment at the University of Illinois. The research aims to investigate the multicellular interactions and tissue tropism that drive the initiation and invasion of endometriotic lesions, which...
This Project Grant award of $6,154,752, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research aimed at understanding how menstrual pain and bladder hypersensitivity interact to promote chronic pelvic pain (CPP). The 3-year study, starting on September 17, 2024, will be conducted by Endeavor Health Clinical Operations, a non-profit research institute at Evanston Hospital. The project will...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research, totaling $2,163,115, will fund research to disentangle the genetic mechanisms of endometriosis severity using single-cell multi-omics analysis. The award will support a collaborative, multidisciplinary research team to perform large-scale single-cell epigenomic profiling, dissect allele-specific gene regulation, and...
This federal Project Grant award of $1,726,800, provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 Child Health and Human Development Extramural Research, supports a longitudinal mixed-methods study examining the role of peer relationships in pediatric pain. The study aims to identify specific peer relationship processes that influence pain persistence, exacerbation, and recovery in a cohort of 450 early adolescents (ages...
The federal Project Grant award SB1HD118921 was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865). The $2,045,782 award, granted on April 10, 2025, is supporting the development of ENDO-205, a novel, non-hormonal therapeutic for endometriosis, a prevalent and debilitating women's health condition that currently lacks an effective cure. The project aims...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is funding research at the Morehouse School of Medicine to investigate the use of novel nitro-fatty acid-based STING inhibitors as a non-hormonal therapeutic approach for treating endometriosis. The $578,397 award, effective July 7, 2025 through March 31, 2030, will support pre-clinical studies to define the...
This Project Grant award of $252,678 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research, aims to develop a novel, non-invasive gas sensor technology for early detection of endometriosis. The key products and services to be delivered include: 1) Detecting and distinguishing endometriosis vs. healthy cells by analyzing volatile organic compound (VOC) mixtures from 2D and 3D cell...
The National Institute of Child Health and Human Development (NICHD) awarded a $759,944 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to Nextgenjane Inc., a women's health startup in Oakland, California. The grant supports the development and validation of a non-invasive, genomic-based diagnostic test for endometriosis using menstrual fluid samples. Nextgenjane has created a specialized menstrual fluid collection system and preliminary...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the federal Child Health and Human Development Extramural Research program (CFDA 93.865), provides $384,418 to Serentrix LLC to validate the efficacy of their lead compound SER-014, a TRPV1 receptor antagonist, for treating endometriosis. The project aims to 1) measure the efficacy of SER-014 in reducing pain and lesion size in a validated mouse model of endometriosis, and 2) confirm the...

This $163,320 Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports the development, testing, and implementation of the Peer Empowered Endometriosis Pain Support (PEEPS) intervention. PEEPS is an 8-session group care program that incorporates evidence-based approaches such as physical therapy, mindfulness, yoga, nutrition, and chronic pain management strategies to address endometriosis-associated pain. The grant recipient, The Washington University in St. Louis, will conduct a pilot single-site randomized controlled trial to evaluate the preliminary effectiveness of PEEPS in reducing pain interference, improving quality of life, and decreasing pain catastrophizing in endometriosis patients, compared to an education-only control group. In parallel, the project will assess the barriers, facilitators, and implementability of PEEPS to optimize the intervention for potential scale-up and a future multi-site randomized controlled trial.

Generated 7/1/25, 5:08 AM